$Medpace (MEDP.US)$Revenue, operating profit, and net income...
$Medpace (MEDP.US)$Revenue, operating profit, and net income have all maintained rapid growth over the past 5 years, with average growth rates of 27.3%, 33.9%, 44.3% respectively.
In Q1 2023, revenue increased by 31.2%, operating profit increased by 34.3%, and net income increased by only 18.9% due to fluctuating income tax.
Over the past 5 years, the asset-liability ratio has increased from 39% to 71.4%. The proportion and growth rate of accounts receivable are considered normal, and there is no inventory.
Goodwill is 0.7 billion, twice the net assets of 0.347 billion, indicating a low level of asset liquidity.
Recently, short-term borrowings have grown rapidly, which may be due to the increased demand for operating capital caused by rapid business growth.
The share capital has been declining, indicating that the company directly cancels shares after repurchasing them, which is beneficial for EPS growth.
For the past five years, the net operating cash flow has been much higher than the net investment cash flow, resulting in a large amount of shareholder surplus.
Currently, the P/E ratio is 33.6, and the TTM P/E ratio has dropped to 31.2. You can choose (⭐️⭐️).
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment